Cargando…

Improving Treatment Outcome for Cervical Cancer Using 2-Point Assessment of Quality of Life Among Nigerian Women: A Protocol for a Multi-Center Study

BACKGROUND: Cervical cancer is the fourth most common cancer among women globally, with quality of life (QOL) being a major concern for patients with cervical cancer, especially in low- and middle-income countries (LMICs). This is largely due to the advanced nature of the disease at presentation. Al...

Descripción completa

Detalles Bibliográficos
Autores principales: Umemmuo, Maureen Uche, Eleje, George Uchenna, Oluwasola, Timothy A, Ezeanochie, Michael, Usman, Hadiza Abdullahi, Galadanci, Jawhara Shehu, Agbanu, Chiemezie Mac-Kingsley, Rabiu, Ayyuba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644736/
https://www.ncbi.nlm.nih.gov/pubmed/38023287
http://dx.doi.org/10.1177/11795549231212339
_version_ 1785147283666370560
author Umemmuo, Maureen Uche
Eleje, George Uchenna
Oluwasola, Timothy A
Ezeanochie, Michael
Usman, Hadiza Abdullahi
Galadanci, Jawhara Shehu
Agbanu, Chiemezie Mac-Kingsley
Rabiu, Ayyuba
author_facet Umemmuo, Maureen Uche
Eleje, George Uchenna
Oluwasola, Timothy A
Ezeanochie, Michael
Usman, Hadiza Abdullahi
Galadanci, Jawhara Shehu
Agbanu, Chiemezie Mac-Kingsley
Rabiu, Ayyuba
author_sort Umemmuo, Maureen Uche
collection PubMed
description BACKGROUND: Cervical cancer is the fourth most common cancer among women globally, with quality of life (QOL) being a major concern for patients with cervical cancer, especially in low- and middle-income countries (LMICs). This is largely due to the advanced nature of the disease at presentation. Although there are a higher number of studies focusing on the QOL of high-income countries, the QOL of cervical cancer patients in LMICs is not available. The aim of this study is to evaluate QOL among women with cervical cancer in Nigeria using a 2-point assessment. METHODS: A multi-center prospective cohort study will be conducted in 6 tertiary health facilities randomly selected from the 6 geopolitical zones of Nigeria and consisting of a 2-point assessment of the QOL of participants at the time of diagnosis of cervical cancer and after treatment. Women who were recently diagnosed with histologically confirmed cervical cancer (treatment naïve) will be included. QOL will be assessed using Quality of Life Questionnaire domains (EORTC QLQ30) as developed by the European Organization for Research and Treatment of Cancer (EORTC). In addition to the QOL assessment, relevant and clinicopathological variables will be obtained using a self-structured data extraction sheet designed for this study. All data will be anonymized and will be analyzed using SPSS version 25. Levels of QOL will be calculated using EORTC QLQ30. Ethical approval was obtained from National Health Research Ethics Committee (NHREC/01/01/2007-08/11/2021). DISCUSSION: In view of the paucity of data on QOL in LMICs like Nigeria, where most women with cervical cancer present with advanced disease, this research was designed to help in formulating evidence-based interventions to improve the QOL and treatment outcomes provided to women with cervical cancer in Nigeria and other LMICs. The study is expected to fill these knowledge gaps.
format Online
Article
Text
id pubmed-10644736
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-106447362023-11-14 Improving Treatment Outcome for Cervical Cancer Using 2-Point Assessment of Quality of Life Among Nigerian Women: A Protocol for a Multi-Center Study Umemmuo, Maureen Uche Eleje, George Uchenna Oluwasola, Timothy A Ezeanochie, Michael Usman, Hadiza Abdullahi Galadanci, Jawhara Shehu Agbanu, Chiemezie Mac-Kingsley Rabiu, Ayyuba Clin Med Insights Oncol Study Protocol BACKGROUND: Cervical cancer is the fourth most common cancer among women globally, with quality of life (QOL) being a major concern for patients with cervical cancer, especially in low- and middle-income countries (LMICs). This is largely due to the advanced nature of the disease at presentation. Although there are a higher number of studies focusing on the QOL of high-income countries, the QOL of cervical cancer patients in LMICs is not available. The aim of this study is to evaluate QOL among women with cervical cancer in Nigeria using a 2-point assessment. METHODS: A multi-center prospective cohort study will be conducted in 6 tertiary health facilities randomly selected from the 6 geopolitical zones of Nigeria and consisting of a 2-point assessment of the QOL of participants at the time of diagnosis of cervical cancer and after treatment. Women who were recently diagnosed with histologically confirmed cervical cancer (treatment naïve) will be included. QOL will be assessed using Quality of Life Questionnaire domains (EORTC QLQ30) as developed by the European Organization for Research and Treatment of Cancer (EORTC). In addition to the QOL assessment, relevant and clinicopathological variables will be obtained using a self-structured data extraction sheet designed for this study. All data will be anonymized and will be analyzed using SPSS version 25. Levels of QOL will be calculated using EORTC QLQ30. Ethical approval was obtained from National Health Research Ethics Committee (NHREC/01/01/2007-08/11/2021). DISCUSSION: In view of the paucity of data on QOL in LMICs like Nigeria, where most women with cervical cancer present with advanced disease, this research was designed to help in formulating evidence-based interventions to improve the QOL and treatment outcomes provided to women with cervical cancer in Nigeria and other LMICs. The study is expected to fill these knowledge gaps. SAGE Publications 2023-11-14 /pmc/articles/PMC10644736/ /pubmed/38023287 http://dx.doi.org/10.1177/11795549231212339 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Study Protocol
Umemmuo, Maureen Uche
Eleje, George Uchenna
Oluwasola, Timothy A
Ezeanochie, Michael
Usman, Hadiza Abdullahi
Galadanci, Jawhara Shehu
Agbanu, Chiemezie Mac-Kingsley
Rabiu, Ayyuba
Improving Treatment Outcome for Cervical Cancer Using 2-Point Assessment of Quality of Life Among Nigerian Women: A Protocol for a Multi-Center Study
title Improving Treatment Outcome for Cervical Cancer Using 2-Point Assessment of Quality of Life Among Nigerian Women: A Protocol for a Multi-Center Study
title_full Improving Treatment Outcome for Cervical Cancer Using 2-Point Assessment of Quality of Life Among Nigerian Women: A Protocol for a Multi-Center Study
title_fullStr Improving Treatment Outcome for Cervical Cancer Using 2-Point Assessment of Quality of Life Among Nigerian Women: A Protocol for a Multi-Center Study
title_full_unstemmed Improving Treatment Outcome for Cervical Cancer Using 2-Point Assessment of Quality of Life Among Nigerian Women: A Protocol for a Multi-Center Study
title_short Improving Treatment Outcome for Cervical Cancer Using 2-Point Assessment of Quality of Life Among Nigerian Women: A Protocol for a Multi-Center Study
title_sort improving treatment outcome for cervical cancer using 2-point assessment of quality of life among nigerian women: a protocol for a multi-center study
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644736/
https://www.ncbi.nlm.nih.gov/pubmed/38023287
http://dx.doi.org/10.1177/11795549231212339
work_keys_str_mv AT umemmuomaureenuche improvingtreatmentoutcomeforcervicalcancerusing2pointassessmentofqualityoflifeamongnigerianwomenaprotocolforamulticenterstudy
AT elejegeorgeuchenna improvingtreatmentoutcomeforcervicalcancerusing2pointassessmentofqualityoflifeamongnigerianwomenaprotocolforamulticenterstudy
AT oluwasolatimothya improvingtreatmentoutcomeforcervicalcancerusing2pointassessmentofqualityoflifeamongnigerianwomenaprotocolforamulticenterstudy
AT ezeanochiemichael improvingtreatmentoutcomeforcervicalcancerusing2pointassessmentofqualityoflifeamongnigerianwomenaprotocolforamulticenterstudy
AT usmanhadizaabdullahi improvingtreatmentoutcomeforcervicalcancerusing2pointassessmentofqualityoflifeamongnigerianwomenaprotocolforamulticenterstudy
AT galadancijawharashehu improvingtreatmentoutcomeforcervicalcancerusing2pointassessmentofqualityoflifeamongnigerianwomenaprotocolforamulticenterstudy
AT agbanuchiemeziemackingsley improvingtreatmentoutcomeforcervicalcancerusing2pointassessmentofqualityoflifeamongnigerianwomenaprotocolforamulticenterstudy
AT rabiuayyuba improvingtreatmentoutcomeforcervicalcancerusing2pointassessmentofqualityoflifeamongnigerianwomenaprotocolforamulticenterstudy